Sanofi Q1: robust 7% sales growth driven by launches, underpins full-year guidance
from Sanofi - Aventis Groupe https://ift.tt/dmxrqZt
via IFTTT
Sanofi Q1: robust 7% sales growth driven by launches, underpins full-year guidance
Media Update: New data presented at ATS demonstrate Sanofi’s leadership in advancing potential new therapies for patients with immune-mediated respiratory diseases
Press Release: Rilzabrutinib LUNA 3 phase 3 study met primary endpoint in immune thrombocytopenia
0 Comments
Please ,
Do not enter any kind of span link